Response and progression-free survival in 1006 patients with known EGFR mutation status in phase III randomized trials of gefitinib in individuals with non-small cell lung cancer
Other conference paper


Times Cited
Web of Science3WOS source URL (as at 12/07/2020) Click here for the latest count
Altmetrics Information
.

Other information
All Author(s) ListKris M, Mok T, Kim E, Douillard JY, Fukuoka M, Thatcher N
Name of Conference15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology
Start Date of Conference20/09/2009
End Date of Conference24/09/2009
Place of ConferenceBerlin
Country/Region of ConferenceGermany
Journal nameEJC Supplements
Detailed descriptionorganized by European Society of Medical Oncology,
Year2009
Month9
Day1
Volume Number7
Issue Number2
PublisherPERGAMON-ELSEVIER SCIENCE LTD
Pages505 - 506
ISSN1359-6349
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesOncology

Last updated on 2020-13-07 at 01:31